ClinicalTrials.Veeva

Menu

Clinical Study of Endocardial Myocardial Biopsy

Zhejiang University logo

Zhejiang University

Status and phase

Enrolling
Phase 4

Conditions

Cardiac Tumor
Myocarditis
Heart Failure
Cardiomyopathies
Endocardiomyocardial Biopsy

Treatments

Procedure: Endocardiomyocardial biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT05718128
2021-0131

Details and patient eligibility

About

In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine;
  • Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause;
  • Have the ability to understand the test, can cooperate with investigators.

Exclusion criteria

  • Unable to understand or unwilling to fill in informed consent forms or follow visitors.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Biopsy
Experimental group
Description:
patients
Treatment:
Procedure: Endocardiomyocardial biopsy

Trial contacts and locations

1

Loading...

Central trial contact

XiaoHong PAN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems